Global Large Molecule Injectable Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: GBD88A97B8E1EN
QYResearch

Abstracts

This report focuses on the global Large Molecule Injectable Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Large Molecule Injectable Drugs development in North America, Europe and Asia-Pacific.

The key players covered in this study

• Biogen
• AstraZeneca
• Roche
• Sun Pharmaceutical
• Medtronic
• Novartis
• ??Baxter
• Amgen
• Pfizer
• Johnson & Johnson

Market segment by Type, the product can be split into

• Intravenous Injection
• Muscle Injection
• Subcutaneous Injection

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Large Molecule Injectable Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Large Molecule Injectable Drugs development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Large Molecule Injectable Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Large Molecule Injectable Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Large Molecule Injectable Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Intravenous Injection
  1.4.3 Muscle Injection
  1.4.4 Subcutaneous Injection
1.5 Market by Application
  1.5.1 Global Large Molecule Injectable Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Large Molecule Injectable Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Large Molecule Injectable Drugs Industry
    1.6.1.1 Large Molecule Injectable Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Large Molecule Injectable Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Large Molecule Injectable Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Large Molecule Injectable Drugs Market Perspective (2015-2026)
2.2 Large Molecule Injectable Drugs Growth Trends by Regions
  2.2.1 Large Molecule Injectable Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Large Molecule Injectable Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Large Molecule Injectable Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Large Molecule Injectable Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Large Molecule Injectable Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Large Molecule Injectable Drugs Players by Market Size
  3.1.1 Global Top Large Molecule Injectable Drugs Players by Revenue (2015-2020)
  3.1.2 Global Large Molecule Injectable Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Large Molecule Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Large Molecule Injectable Drugs Market Concentration Ratio
  3.2.1 Global Large Molecule Injectable Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Large Molecule Injectable Drugs Revenue in 2019
3.3 Large Molecule Injectable Drugs Key Players Head office and Area Served
3.4 Key Players Large Molecule Injectable Drugs Product Solution and Service
3.5 Date of Enter into Large Molecule Injectable Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Large Molecule Injectable Drugs Historic Market Size by Type (2015-2020)
4.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Type (2021-2026)

5 LARGE MOLECULE INJECTABLE DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Large Molecule Injectable Drugs Market Size by Application (2015-2020)
5.2 Global Large Molecule Injectable Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Large Molecule Injectable Drugs Market Size (2015-2020)
6.2 Large Molecule Injectable Drugs Key Players in North America (2019-2020)
6.3 North America Large Molecule Injectable Drugs Market Size by Type (2015-2020)
6.4 North America Large Molecule Injectable Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Large Molecule Injectable Drugs Market Size (2015-2020)
7.2 Large Molecule Injectable Drugs Key Players in Europe (2019-2020)
7.3 Europe Large Molecule Injectable Drugs Market Size by Type (2015-2020)
7.4 Europe Large Molecule Injectable Drugs Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Large Molecule Injectable Drugs Market Size (2015-2020)
8.2 Large Molecule Injectable Drugs Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2015-2020)
8.4 Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 Biogen
  9.1.1 Biogen Company Details
  9.1.2 Biogen Business Overview and Its Total Revenue
  9.1.3 Biogen Large Molecule Injectable Drugs Introduction
  9.1.4 Biogen Revenue in Large Molecule Injectable Drugs Business (2015-2020))
  9.1.5 Biogen Recent Development
9.2 AstraZeneca
  9.2.1 AstraZeneca Company Details
  9.2.2 AstraZeneca Business Overview and Its Total Revenue
  9.2.3 AstraZeneca Large Molecule Injectable Drugs Introduction
  9.2.4 AstraZeneca Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.2.5 AstraZeneca Recent Development
9.3 Roche
  9.3.1 Roche Company Details
  9.3.2 Roche Business Overview and Its Total Revenue
  9.3.3 Roche Large Molecule Injectable Drugs Introduction
  9.3.4 Roche Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.3.5 Roche Recent Development
9.4 Sun Pharmaceutical
  9.4.1 Sun Pharmaceutical Company Details
  9.4.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  9.4.3 Sun Pharmaceutical Large Molecule Injectable Drugs Introduction
  9.4.4 Sun Pharmaceutical Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.4.5 Sun Pharmaceutical Recent Development
9.5 Medtronic
  9.5.1 Medtronic Company Details
  9.5.2 Medtronic Business Overview and Its Total Revenue
  9.5.3 Medtronic Large Molecule Injectable Drugs Introduction
  9.5.4 Medtronic Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.5.5 Medtronic Recent Development
9.6 Novartis
  9.6.1 Novartis Company Details
  9.6.2 Novartis Business Overview and Its Total Revenue
  9.6.3 Novartis Large Molecule Injectable Drugs Introduction
  9.6.4 Novartis Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.6.5 Novartis Recent Development
9.7 ??Baxter
  9.7.1 ??Baxter Company Details
  9.7.2 ??Baxter Business Overview and Its Total Revenue
  9.7.3 ??Baxter Large Molecule Injectable Drugs Introduction
  9.7.4 ??Baxter Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.7.5 ??Baxter Recent Development
9.8 Amgen
  9.8.1 Amgen Company Details
  9.8.2 Amgen Business Overview and Its Total Revenue
  9.8.3 Amgen Large Molecule Injectable Drugs Introduction
  9.8.4 Amgen Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.8.5 Amgen Recent Development
9.9 Pfizer
  9.9.1 Pfizer Company Details
  9.9.2 Pfizer Business Overview and Its Total Revenue
  9.9.3 Pfizer Large Molecule Injectable Drugs Introduction
  9.9.4 Pfizer Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.9.5 Pfizer Recent Development
9.10 Johnson & Johnson
  9.10.1 Johnson & Johnson Company Details
  9.10.2 Johnson & Johnson Business Overview and Its Total Revenue
  9.10.3 Johnson & Johnson Large Molecule Injectable Drugs Introduction
  9.10.4 Johnson & Johnson Revenue in Large Molecule Injectable Drugs Business (2015-2020)
  9.10.5 Johnson & Johnson Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Large Molecule Injectable Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Large Molecule Injectable Drugs Revenue
Table 3. Ranking of Global Top Large Molecule Injectable Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Large Molecule Injectable Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous Injection
Table 6. Key Players of Muscle Injection
Table 7. Key Players of Subcutaneous Injection
Table 8. COVID-19 Impact Global Market: (Four Large Molecule Injectable Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Large Molecule Injectable Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Large Molecule Injectable Drugs Players to Combat Covid-19 Impact
Table 13. Global Large Molecule Injectable Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Large Molecule Injectable Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Large Molecule Injectable Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Large Molecule Injectable Drugs Market Share by Regions (2015-2020)
Table 17. Global Large Molecule Injectable Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Large Molecule Injectable Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Large Molecule Injectable Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Large Molecule Injectable Drugs Players
Table 24. Global Large Molecule Injectable Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Large Molecule Injectable Drugs Market Share by Players (2015-2020)
Table 26. Global Top Large Molecule Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Molecule Injectable Drugs as of 2019)
Table 27. Global Large Molecule Injectable Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Large Molecule Injectable Drugs Product Solution and Service
Table 30. Date of Enter into Large Molecule Injectable Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Large Molecule Injectable Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Large Molecule Injectable Drugs Market Size Share by Type (2015-2020)
Table 34. Global Large Molecule Injectable Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Large Molecule Injectable Drugs Market Size Share by Application (2015-2020)
Table 36. Global Large Molecule Injectable Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Large Molecule Injectable Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Large Molecule Injectable Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Large Molecule Injectable Drugs Market Share (2019-2020)
Table 40. North America Large Molecule Injectable Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Large Molecule Injectable Drugs Market Share by Type (2015-2020)
Table 42. North America Large Molecule Injectable Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Large Molecule Injectable Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Large Molecule Injectable Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Large Molecule Injectable Drugs Market Share (2019-2020)
Table 46. Europe Large Molecule Injectable Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Large Molecule Injectable Drugs Market Share by Type (2015-2020)
Table 48. Europe Large Molecule Injectable Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Large Molecule Injectable Drugs Market Share by Application (2015-2020)
Table 50. Asia-Pacific Key Players Large Molecule Injectable Drugs Revenue (2019-2020) (Million US$)
Table 51. Asia-Pacific Key Players Large Molecule Injectable Drugs Market Share (2019-2020)
Table 52. Asia-Pacific Large Molecule Injectable Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Asia-Pacific Large Molecule Injectable Drugs Market Share by Type (2015-2020)
Table 54. Asia-Pacific Large Molecule Injectable Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Asia-Pacific Large Molecule Injectable Drugs Market Share by Application (2015-2020)
Table 56. Biogen Company Details
Table 57. Biogen Business Overview
Table 58. Biogen Product
Table 59. Biogen Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 60. Biogen Recent Development
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Product
Table 64. AstraZeneca Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 65. AstraZeneca Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Product
Table 69. Roche Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 70. Roche Recent Development
Table 71. Sun Pharmaceutical Company Details
Table 72. Sun Pharmaceutical Business Overview
Table 73. Sun Pharmaceutical Product
Table 74. Sun Pharmaceutical Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 75. Sun Pharmaceutical Recent Development
Table 76. Medtronic Company Details
Table 77. Medtronic Business Overview
Table 78. Medtronic Product
Table 79. Medtronic Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 80. Medtronic Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. ??Baxter Company Details
Table 87. ??Baxter Business Overview
Table 88. ??Baxter Product
Table 89. ??Baxter Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 90. ??Baxter Recent Development
Table 91. Amgen Business Overview
Table 92. Amgen Product
Table 93. Amgen Company Details
Table 94. Amgen Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 95. Amgen Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Product
Table 99. Pfizer Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 100. Pfizer Recent Development
Table 101. Johnson & Johnson Company Details
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Revenue in Large Molecule Injectable Drugs Business (2015-2020) (Million US$)
Table 105. Johnson & Johnson Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Large Molecule Injectable Drugs Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Injection Features
Figure 3. Muscle Injection Features
Figure 4. Subcutaneous Injection Features
Figure 5. Global Large Molecule Injectable Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Large Molecule Injectable Drugs Report Years Considered
Figure 10. Global Large Molecule Injectable Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Large Molecule Injectable Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Large Molecule Injectable Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Large Molecule Injectable Drugs Market Share by Players in 2019
Figure 15. Global Top Large Molecule Injectable Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Molecule Injectable Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Large Molecule Injectable Drugs Revenue in 2019
Figure 17. North America Large Molecule Injectable Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Large Molecule Injectable Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Asia-Pacific Large Molecule Injectable Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 21. Biogen Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 22. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. AstraZeneca Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 24. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Roche Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 26. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sun Pharmaceutical Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 28. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Medtronic Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 32. ??Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. ??Baxter Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 34. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Amgen Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Pfizer Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 38. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Johnson & Johnson Revenue Growth Rate in Large Molecule Injectable Drugs Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed